These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Occurrence of gram negative bacteria in midstream bladder urine and their sensitivity to quinoline derivatives. Esposito S; Galante D; Pennucci C; Barba D Microbiologica; 1985 Jul; 8(3):269-76. PubMed ID: 3162081 [TBL] [Abstract][Full Text] [Related]
25. Bactericidal intraprostatic concentrations of norfloxacin. Bologna M; Vaggi L; Forchetti CM; Martini E Lancet; 1983 Jul; 2(8344):280. PubMed ID: 6135100 [No Abstract] [Full Text] [Related]
26. The pharmacokinetics and tissue penetration of norfloxacin. Adhami ZN; Wise R; Weston D; Crump B J Antimicrob Chemother; 1984 Jan; 13(1):87-92. PubMed ID: 6230344 [TBL] [Abstract][Full Text] [Related]
27. The fluoroquinolones for urinary tract infections: a review. Cunha BA Adv Ther; 1994; 11(6):277-96. PubMed ID: 10150268 [TBL] [Abstract][Full Text] [Related]
33. Frequency and expression of mutational resistance to the 4-quinolone antibacterials. Smith JT Scand J Infect Dis Suppl; 1986; 49():115-23. PubMed ID: 3547618 [TBL] [Abstract][Full Text] [Related]
34. Norfloxacin, amoxycillin, cotrimoxazole and nalidixic acid. A summary of 3-day and 7-day therapy studies in the treatment of urinary tract infections. Vogel R; Deaney NB; Round EM; VandenBurg MJ; Currie WJ J Antimicrob Chemother; 1984 May; 13 Suppl B():113-20. PubMed ID: 6234271 [TBL] [Abstract][Full Text] [Related]
35. The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens. O'Hare MD; Felmingham D; Ridgway GL; Grüneberg RN Drugs Exp Clin Res; 1985; 11(4):253-7. PubMed ID: 2941257 [TBL] [Abstract][Full Text] [Related]
36. The in-vitro activity of EN 272, a quinolone-7-carboxylic acid, in comparison with other quinolones. Neu HC J Antimicrob Chemother; 1985 Jul; 16(1):43-8. PubMed ID: 3862659 [TBL] [Abstract][Full Text] [Related]
37. [Norfloxacin sensitivity of bacterial pathogens of urinary tract infections]. Modde H Schweiz Rundsch Med Prax; 1985 Apr; 74(17):439-42. PubMed ID: 3159064 [No Abstract] [Full Text] [Related]
38. In-vitro activity of antifungal agents in combination with four quinolones. Petrou MA; Rogers TR Drugs Exp Clin Res; 1988; 14(1):9-18. PubMed ID: 3292181 [TBL] [Abstract][Full Text] [Related]
39. Enrofloxacin concentrations in dogs with normal prostate and dogs with chronic bacterial prostatitis. Dorfman M; Barsanti J; Budsberg SC Am J Vet Res; 1995 Mar; 56(3):386-90. PubMed ID: 7771709 [TBL] [Abstract][Full Text] [Related]